Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size, Status and Forecast 2025

January 2018 | 97 pages | ID: GE4A94BBEA8EN
QYResearch

Abstracts

This report studies the global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) market, analyzes and researches the Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) development status and forecast in United States, EU, Japan, China, India and Southeast Asia.
This report focuses on the top players in global market, like

• Qiagen NV
• GE Healthcare
• Agilent Technologies
• F Hoffman La Roche
• Foundation Medicine
• Thermo Fisher Scientific Inc.
• Leica Biosystems Nussloch GmBH
• Pfizer

Market segment by Regions/Countries, this report covers

• United States
• EU
• Japan
• China
• India
• Southeast Asia

Market segment by Type, the product can be split into

• PCR
• In-situ Hybridization
• Immunohistochemistry
• Sequencing
• Others

Market segment by Application, Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) can be split into

• Oncology
• Neurological Disorders
• Cardiovascular Disease
• Immunological Disorders
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size, Status and Forecast 2025

1 INDUSTRY OVERVIEW OF PHARMACOGENOMICS TECHNOLOGY/THERANOSTICS/COMPANION DIAGNOSTICS (CDX)

1.1 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Overview
  1.1.1 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Product Scope
  1.1.2 Market Status and Outlook
1.2 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size and Analysis by Regions (2013-2018)
  1.2.1 United States
  1.2.2 EU
  1.2.3 Japan
  1.2.4 China
  1.2.5 India
  1.2.6 Southeast Asia
1.3 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market by Type
  1.3.1 PCR
  1.3.2 In-situ Hybridization
  1.3.3 Immunohistochemistry
  1.3.4 Sequencing
  1.3.5 Others
1.4 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market by End Users/Application
  1.4.1 Oncology
  1.4.2 Neurological Disorders
  1.4.3 Cardiovascular Disease
  1.4.4 Immunological Disorders
  1.4.5 Others

2 GLOBAL PHARMACOGENOMICS TECHNOLOGY/THERANOSTICS/COMPANION DIAGNOSTICS (CDX) COMPETITION ANALYSIS BY PLAYERS

2.1 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (Value) by Players (2013-2018)
2.2 Competitive Status and Trend
  2.2.1 Market Concentration Rate
  2.2.2 Product/Service Differences
  2.2.3 New Entrants
  2.2.4 The Technology Trends in Future

3 COMPANY (TOP PLAYERS) PROFILES

3.1 Qiagen NV
  3.1.1 Company Profile
  3.1.2 Main Business/Business Overview
  3.1.3 Products, Services and Solutions
  3.1.4 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (Million USD) (2013-2018)
  3.1.5 Recent Developments
3.2 GE Healthcare
  3.2.1 Company Profile
  3.2.2 Main Business/Business Overview
  3.2.3 Products, Services and Solutions
  3.2.4 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (Million USD) (2013-2018)
  3.2.5 Recent Developments
3.3 Agilent Technologies
  3.3.1 Company Profile
  3.3.2 Main Business/Business Overview
  3.3.3 Products, Services and Solutions
  3.3.4 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (Million USD) (2013-2018)
  3.3.5 Recent Developments
3.4 F Hoffman La Roche
  3.4.1 Company Profile
  3.4.2 Main Business/Business Overview
  3.4.3 Products, Services and Solutions
  3.4.4 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (Million USD) (2013-2018)
  3.4.5 Recent Developments
3.5 Foundation Medicine
  3.5.1 Company Profile
  3.5.2 Main Business/Business Overview
  3.5.3 Products, Services and Solutions
  3.5.4 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (Million USD) (2013-2018)
  3.5.5 Recent Developments
3.6 Thermo Fisher Scientific Inc.
  3.6.1 Company Profile
  3.6.2 Main Business/Business Overview
  3.6.3 Products, Services and Solutions
  3.6.4 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (Million USD) (2013-2018)
  3.6.5 Recent Developments
3.7 Leica Biosystems Nussloch GmBH
  3.7.1 Company Profile
  3.7.2 Main Business/Business Overview
  3.7.3 Products, Services and Solutions
  3.7.4 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (Million USD) (2013-2018)
  3.7.5 Recent Developments
3.8 Pfizer
  3.8.1 Company Profile
  3.8.2 Main Business/Business Overview
  3.8.3 Products, Services and Solutions
  3.8.4 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (Million USD) (2013-2018)
  3.8.5 Recent Developments

4 GLOBAL PHARMACOGENOMICS TECHNOLOGY/THERANOSTICS/COMPANION DIAGNOSTICS (CDX) MARKET SIZE BY TYPE AND APPLICATION (2013-2018)

4.1 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type (2013-2018)
4.2 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2013-2018)
4.3 Potential Application of Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) in Future
4.4 Top Consumer/End Users of Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx)

5 UNITED STATES PHARMACOGENOMICS TECHNOLOGY/THERANOSTICS/COMPANION DIAGNOSTICS (CDX) DEVELOPMENT STATUS AND OUTLOOK

5.1 United States Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (2013-2018)
5.2 United States Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size and Market Share by Players (2013-2018)
5.3 United States Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2013-2018)

6 EU PHARMACOGENOMICS TECHNOLOGY/THERANOSTICS/COMPANION DIAGNOSTICS (CDX) DEVELOPMENT STATUS AND OUTLOOK

6.1 EU Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (2013-2018)
6.2 EU Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size and Market Share by Players (2013-2018)
6.3 EU Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2013-2018)

7 JAPAN PHARMACOGENOMICS TECHNOLOGY/THERANOSTICS/COMPANION DIAGNOSTICS (CDX) DEVELOPMENT STATUS AND OUTLOOK

7.1 Japan Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (2013-2018)
7.2 Japan Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size and Market Share by Players (2013-2018)
7.3 Japan Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2013-2018)

8 CHINA PHARMACOGENOMICS TECHNOLOGY/THERANOSTICS/COMPANION DIAGNOSTICS (CDX) DEVELOPMENT STATUS AND OUTLOOK

8.1 China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (2013-2018)
8.2 China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size and Market Share by Players (2013-2018)
8.3 China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2013-2018)

9 INDIA PHARMACOGENOMICS TECHNOLOGY/THERANOSTICS/COMPANION DIAGNOSTICS (CDX) DEVELOPMENT STATUS AND OUTLOOK

9.1 India Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (2013-2018)
9.2 India Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size and Market Share by Players (2013-2018)
9.3 India Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2013-2018)

10 SOUTHEAST ASIA PHARMACOGENOMICS TECHNOLOGY/THERANOSTICS/COMPANION DIAGNOSTICS (CDX) DEVELOPMENT STATUS AND OUTLOOK

10.1 Southeast Asia Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (2013-2018)
10.2 Southeast Asia Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size and Market Share by Players (2013-2018)
10.3 Southeast Asia Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2013-2018)

11 MARKET FORECAST BY REGIONS, TYPE AND APPLICATION (2018-2025)

11.1 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (Value) by Regions (2018-2025)
  11.1.1 United States Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue and Growth Rate (2018-2025)
  11.1.2 EU Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue and Growth Rate (2018-2025)
  11.1.3 Japan Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue and Growth Rate (2018-2025)
  11.1.4 China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue and Growth Rate (2018-2025)
  11.1.5 India Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue and Growth Rate (2018-2025)
  11.1.6 Southeast Asia Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue and Growth Rate (2018-2025)
11.2 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (Value) by Type (2018-2025)
11.3 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2018-2025)

12 PHARMACOGENOMICS TECHNOLOGY/THERANOSTICS/COMPANION DIAGNOSTICS (CDX) MARKET DYNAMICS

12.1 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Opportunities
12.2 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Challenge and Risk
  12.2.1 Competition from Opponents
  12.2.2 Downside Risks of Economy
12.3 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Constraints and Threat
  12.3.1 Threat from Substitute
  12.3.2 Government Policy
  12.3.3 Technology Risks
12.4 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Driving Force
  12.4.1 Growing Demand from Emerging Markets
  12.4.2 Potential Application

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
  13.3.1 Economic Fluctuations
  13.3.2 Other Risk Factors

14 RESEARCH FINDING/CONCLUSION

15 APPENDIX

Methodology
Analyst Introduction
Data Source


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (Million USD) Status and Outlook (2013-2018)
Table Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (Million USD) Comparison by Regions (2013-2018)
Figure Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Regions (2013-2018)
Figure United States Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure EU Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Japan Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure India Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Southeast Asia Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Table Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (Million USD) and Growth Rate (%) Comparison by Product (2013-2018)
Figure Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue Market Share by Type in 2017
Figure PCR Market Size (Million USD) and Growth Rate (2013-2018)
Figure In-situ Hybridization Market Size (Million USD) and Growth Rate (2013-2018)
Figure Immunohistochemistry Market Size (Million USD) and Growth Rate (2013-2018)
Figure Sequencing Market Size (Million USD) and Growth Rate (2013-2018)
Figure Others Market Size (Million USD) and Growth Rate (2013-2018)
Figure Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Application in 2017
Figure Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (Million USD) and Growth Rate in Oncology (2013-2018)
Figure Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (Million USD) and Growth Rate in Neurological Disorders (2013-2018)
Figure Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (Million USD) and Growth Rate in Cardiovascular Disease (2013-2018)
Figure Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (Million USD) and Growth Rate in Immunological Disorders (2013-2018)
Figure Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (Million USD) and Growth Rate in Others (2013-2018)
Table Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (Million USD) by Players (2013-2018)
Figure Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Share by Players in 2013
Figure Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Share by Players in 2017
Table Qiagen NV Basic Information List
Table Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business Revenue (Million USD) of Qiagen NV (2013-2018)
Figure Qiagen NV Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business Revenue Market Share (2013-2018)
Table GE Healthcare Basic Information List
Table Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business Revenue (Million USD) of GE Healthcare (2013-2018)
Figure GE Healthcare Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business Revenue Market Share (2013-2018)
Table Agilent Technologies Basic Information List
Table Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business Revenue (Million USD) of Agilent Technologies (2013-2018)
Figure Agilent Technologies Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business Revenue Market Share (2013-2018)
Table F Hoffman La Roche Basic Information List
Table Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business Revenue (Million USD) of F Hoffman La Roche (2013-2018)
Figure F Hoffman La Roche Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business Revenue Market Share (2013-2018)
Table Foundation Medicine Basic Information List
Table Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business Revenue (Million USD) of Foundation Medicine (2013-2018)
Figure Foundation Medicine Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business Revenue Market Share (2013-2018)
Table Thermo Fisher Scientific Inc. Basic Information List
Table Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business Revenue (Million USD) of Thermo Fisher Scientific Inc. (2013-2018)
Figure Thermo Fisher Scientific Inc. Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business Revenue Market Share (2013-2018)
Table Leica Biosystems Nussloch GmBH Basic Information List
Table Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business Revenue (Million USD) of Leica Biosystems Nussloch GmBH (2013-2018)
Figure Leica Biosystems Nussloch GmBH Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business Revenue Market Share (2013-2018)
Table Pfizer Basic Information List
Table Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business Revenue (Million USD) of Pfizer (2013-2018)
Figure Pfizer Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business Revenue Market Share (2013-2018)
Table Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (Million USD) by Product (2013-2018)
Figure Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue Market Share (%) by Product (2013-2018)
Figure Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Product in 2017
Table Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2013-2018)
Figure Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue Market Share (%) by Application in 2017
Table Top Consumer/End Users of Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx)
Figure United States Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (Million USD) and Growth Rate (2013-2018)
Table United States Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (Million USD) by Players (2013-2018)
Figure United States Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Share by Players in 2013
Figure United States Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Share by Players in 2017
Table United States Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2013-2018)
Figure United States Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue Market Share (%) by Application (2013-2018)
Figure United States Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Share by Application in 2017
Figure EU Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (Million USD) and Growth Rate (2013-2018)
Table EU Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (Million USD) by Players (2013-2018)
Figure EU Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Share by Players in 2013
Figure EU Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Share by Players in 2017
Table EU Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2013-2018)
Figure EU Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue Market Share (%) by Application (2013-2018)
Figure EU Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Share by Application in 2017
Figure Japan Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (Million USD) and Growth Rate (2013-2018)
Table Japan Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (Million USD) by Players (2013-2018)
Figure Japan Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Share by Players in 2013
Figure Japan Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Share by Players in 2017
Table Japan Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2013-2018)
Figure Japan Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue Market Share (%) by Application (2013-2018)
Figure Japan Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Share by Application in 2017
Figure China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (Million USD) and Growth Rate (2013-2018)
Table China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (Million USD) by Players (2013-2018)
Figure China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Share by Players in 2013
Figure China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Share by Players in 2017
Table China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2013-2018)
Figure China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue Market Share (%) by Application (2013-2018)
Figure China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Share by Application in 2017
Figure India Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (Million USD) and Growth Rate (2013-2018)
Table India Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (Million USD) by Players (2013-2018)
Figure India Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Share by Players in 2013
Figure India Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Share by Players in 2017
Table India Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2013-2018)
Figure India Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue Market Share (%) by Application (2013-2018)
Figure India Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Share by Application in 2017
Figure Southeast Asia Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (Million USD) and Growth Rate (2013-2018)
Table Southeast Asia Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (Million USD) by Players (2013-2018)
Figure Southeast Asia Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Share by Players in 2013
Figure Southeast Asia Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Share by Players in 2017
Table Southeast Asia Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2013-2018)
Figure Southeast Asia Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue Market Share (%) by Application (2013-2018)
Figure Southeast Asia Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Share by Application in 2017
Figure Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size and Growth Rate (2018-2025)
Table Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (Million USD) by Regions (2018-2025)
Figure Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Share (2018-2025)
Figure Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Share by Regions in 2025
Figure United States Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (Million USD) and Growth Rate (2018-2025)
Figure EU Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (Million USD) and Growth Rate (2018-2025)
Figure Japan Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (Million USD) and Growth Rate (2018-2025)
Figure China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (Million USD) and Growth Rate (2018-2025)
Figure India Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (Million USD) and Growth Rate (2018-2025)
Figure Southeast Asia Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (Million USD) and Growth Rate (2018-2025)
Table Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (Million USD) by Type (2018-2025)
Figure Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Share by Type in 2018
Figure Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Share by Type in 2025
Table Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (Million USD) by Application (2018-2025)
Figure Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (Million USD) by Application in 2018
Figure Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (Million USD) by Application in 2025